Patient Guide: A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 54 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05139602
Status: ACTIVE_NOT_RECRUITING
Condition: Hidradenitis Suppurativa
Phase: PHASE2

Where You Can Participate

This study is available at 54 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Scottsdale, Arizona
  • • Hot Springs, Arkansas
  • • And 51 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy - Join Clinical Trial NCTNCT05139602

How to Join This Clinical Trial - NCTNCT05139602

Learn how to participate in this PHASE2 trial studying an investigational therapy for Hidradenitis Suppurativa. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hidradenitis Suppurativa. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hidradenitis Suppurativa
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05139602 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 54 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85006 - United States

Status: Contact for availability

Clinical Research Site

Scottsdale, Arizona 85259-5452 - United States

Status: Contact for availability

Clinical Research Site

Hot Springs, Arkansas 71913-6404 - United States

Status: Contact for availability

Clinical Research Site

Fresno, California 93701-2302 - United States

Status: Contact for availability

Clinical Research Site

San Diego, California 92103 - United States

Status: Contact for availability

Clinical Research Site

Thousand Oaks, California 91320-2130 - United States

Status: Contact for availability

Clinical Research Site

Cromwell, Connecticut 06416-1745 - United States

Status: Contact for availability

Clinical Research Site

Boca Raton, Florida 33486-2269 - United States

Status: Contact for availability

Clinical Research Site

Brandon, Florida 33511 - United States

Status: Contact for availability

Clinical Research Site

Margate, Florida 33063 - United States

Status: Contact for availability

And 44 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Hidradenitis Suppurativa:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships